How to treat psoriasis on the eyelid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Eyelid Psoriasis

Start with hydrocortisone 1% ointment once daily to the eyelid skin for 2-4 weeks maximum, combined with calcipotriene ointment in the evening if tolerated, then transition to tacrolimus 0.1% ointment for long-term steroid-sparing maintenance. 1

First-Line Treatment: Low-Potency Corticosteroids

  • Apply hydrocortisone 1% ointment (the only appropriate corticosteroid for eyelids) once daily during acute flares for a maximum of 2-4 weeks 1
  • Add calcipotriene ointment in the evening if the patient tolerates it without irritation 1
  • Use emollients and moisturizers liberally throughout the day to reduce scaling and maintain the skin barrier 1
  • Never use mid-to-high potency corticosteroids on eyelids due to extremely high risk of skin atrophy, telangiectasia, and other serious complications 1, 2

Critical Monitoring During Corticosteroid Use

  • Arrange baseline and periodic intraocular pressure (IOP) measurements when using any corticosteroids periocularly 1
  • Refer immediately to ophthalmology if the patient develops eye pain, vision changes, or signs of corneal involvement 1
  • Even hydrocortisone 1% can cause eyelid atrophy and telangiectasia with chronic uninterrupted use, so intermittent therapy is essential 2

Transition to Steroid-Sparing Maintenance: Tacrolimus

  • After 4 weeks of corticosteroid therapy, taper to every-other-day or weekend-only application, then transition to tacrolimus for chronic management 1
  • Use tacrolimus 0.1% ointment once daily to external eyelids and lid margins for adults (tacrolimus 0.03% for children ages 2-15 years) 1
  • Tacrolimus demonstrates an 89% response rate in managing periocular inflammatory conditions and serves as an excellent long-term option 1
  • Arrange ophthalmology review within 4 weeks when initiating tacrolimus on eyelids 1

Patient Counseling for Tacrolimus

  • Warn patients that tacrolimus may cause initial burning sensation that typically improves with continued use 1
  • Explain that psoriasis is chronic and requires long-term management with intermittent therapy rather than continuous daily treatment 1

Agents to Absolutely Avoid on Eyelids

  • Never use anthralin or coal tar on eyelids due to severe irritation risk 1
  • Do not combine salicylic acid with calcipotriene, as the acidic pH inactivates calcipotriene 1, 3
  • Avoid potent or superpotent corticosteroids (anything stronger than hydrocortisone) on eyelid skin 1

Common Pitfalls

  • Avoid continuous daily corticosteroid application, even with low-potency agents like hydrocortisone—intermittent therapy is mandatory 1
  • Do not abruptly stop corticosteroids after prolonged use; taper frequency gradually to prevent rebound flare 4
  • Recognize that eyelid skin is particularly vulnerable to corticosteroid-induced atrophy and telangiectasia, requiring extra caution 2

When to Refer to Ophthalmology

  • Refer within 4 weeks when using tacrolimus on eyelids for baseline assessment 1
  • Refer immediately (within 24 hours) if severe symptoms develop, including eye pain, vision changes, or corneal involvement 1
  • Refer for routine assessment if mild-to-moderate disease does not respond to topical treatment and lid hygiene 5

References

Guideline

Treatment of Eyelid Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Complications of topical hydrocortisone.

Journal of the American Academy of Dermatology, 1981

Guideline

Topical Treatment for Mild to Moderate Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Scalp Seborrheic Dermatitis and Psoriasis with Tenderness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.